Prognostic significance of matrix metalloproteinase-2, cathepsin D, and tenascin-C expression in colorectal carcinoma

Pathology Research and Practice

Volumn 200, Issue 5, 2004, Pages 379-387

  Sis, Banu ^a   Saǧol, Özgul ^a   Küpelioǧlu, Ali ^a   Sokmen, Selman ^a   Terzi, Cem ^a   Fuzun, Mehmet ^a   Özer, Erdener ^a   Bishop, Paul ^b  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Cathepsin D; Colorectal carcinoma; Matrix metalloproteinase 2; Prognosis; Tenascin C

Indexed keywords

CATHEPSIN D; GELATINASE A; TENASCIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; SURVIVAL TIME;

EID: 3242739498     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prp.2004.02.012     Document Type: Article

References (42)

1. Arao J. Fukui H. Ono Y. et al. Immunohistochemical localization of cathepsin D in colorectal tumors Dis. Colon Rectum 43 2000 396-401
2. Caruso M.L. Valentini A.M. Immunohistochemical p53 overexpression correlated to c-erbB-2 and cathepsin D proteins in colorectal cancer Anticancer Res. 16 1996 3813-3818
3. Chambers A.F. Matrisian L.M. Changing views of the role of matrix metalloproteinases in metastasis J. Natl. Cancer Inst. 89 1997 1260-1270
4. Charous S.J. Stricklin G.P. Netterville J.L. et al. Expression of matrix metalloproteinases in head and neck squamous cell carcinoma Ann. Otol. Rhinol. Laryngol. 106 1997 271-278
5. Cohen A.M. Kelsen D. Saltz L. et al. Adjuvant therapy for colorectal cancer Curr. Problems Surgery 34 1997 611-612
6. H.S. Cooper, Diagnostic Surgical Pathology, 3rd Edition, Lippincott Williams & Wilkins, Philadelphia, 1999, pp. 1413-1468.
7. R.S. Cotran, V. Kumar, S. Robbins, Pathologic Basis of Disease, 5th Edition, W.B.Saunders Company, Philadelphia, 1994, pp. 755-831.
8. D'Errico A. Garbisa S. Liotta L.A. et al. Augmentation of type IV collagenase, laminin receptor, and Ki-67 proliferation antigen associated with human colon, gastric and breast carcinoma progression Mod. Pathol. 4 1991 239-246
9. Emoto K. Yamada Y. Sawada H. et al. Annexin II overexpression correlates with stromal Tenascin-C overexpression. A prognostic marker in colorectal carcinoma Cancer 92 2001 1419-1426
10. Foekens J.A. Look M.P. Vries J.B. et al. Cathepsin D in primary breast cancer: prognostic evaluation involving 2810 patients Br. J. Cancer 79 2 1999 300-307
11. Galandiuk S. Miseljic S. Yang A. et al. Expression of hormone receptors, cathepsin D, and HER-2/neu oncoprotein in normal colon and colonic disease Arch. Surg. 128 1993 637-642
12. Garbett E.A. Reed M.W.R. Brown N.J. Proteolysis in human breast and colorectal cancer Br. J. Cancer 81 1999 287-293
13. Gennari L. Doci R. Rossetti C. Prognostic factors in colorectal cancer Hepato-Gastroenterology 47 2000 310-314
14. Goussia A. Ioachim E. Peschos D. et al. Immunohistochemical expression of cathepsin D in laryngeal epithelial lesions: correlation with CD44 expression, p53 and Rb status and proliferation associated indices Anticancer Res. 19 1999 3055-3060
15. Hanamura N. Yoshida T. Matsumoto E. Kawarada Y. Sakakura T. Expression of fibronectin and tenascin-C mRNA by myofibroblasts, vascular cells and epithelial cells in human colon adenomas and carcinomas Int. J. Cancer 73 1997 10-15
16. Höythtya M. Fridman R. Komarek D. et al. Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies Int. J. Cancer 56 1994 500-505
17. Ioachim E.E. Goussia A.C. Machera M. et al. Immunohistochemical evaluation of cathepsin D expression in colorectal tumors: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices Anticancer Res. 19 1999 2147-2156
18. Iskaros B.F. Tanaka K.E. Hu X. et al. Morphologic pattern of tenascin as a diagnostic biomarker in colon cancer J. Surg. Oncol. 64 1997 98-101
19. Jahkola T. Toivonen T. Virtanen I. et al. Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence Br. J. Cancer. 78 11 1998 1507-1513
20. Jessup M.J. Loda M. Prognostic markers in rectal carcinoma Sem. Surg. Oncol. 15 1998 131-140
21. Jones P.L. Jones F.S. Tenascin-C in development and disease: gene regulation and cell function Matrix Biol. 19 2000 581-596
22. Juhasz A. Bardos H. Repassy G. Adany R. Characteristic distribution patterns of tenascin in laryngeal and hypopharyngeal cancers Laryngoscope 110 2000 84-92
23. Kawano N. Osawa H. Ito T. et al. Expression of gelatinase A, tissue inhibitor of metalloproteinase-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study Hum. Pathol. 28 5 1997 613-622
24. Kressner U. Lindmark G. Tomasini-Johansson B. et al. Stromal tenascin distribution as a prognostic marker in colorectal cancer Br. J. Cancer 76 4 1997 526-530
25. Kusukawa J. Sasaguri Y. Shima I. et al. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma Am. J. Clin. Pathol. 99 1993 18-23
26. Mayer A. Fritz E. Fortelny R. Kofler K. Ludwig H. Immunohistochemical evaluation of cathepsin D expression in colorectal cancer Cancer Invest. 15 2 1997 106-110
27. Meyer T. Hart I.R. Mechanisms of tumour metastasis Eur. J. Cancer 34 2 1998 214-221
28. Ornstein D.L. MacNab J. Cohn K.H. Evidence for tumor-host cooperation in regulating MMP-2 expression in human colon cancer Clin. Exp. Metastasis 17 1999 205-212
29. Parsons S.L. Watson S.A. Collins H.M. et al. Gelatinase (MMP-2 and MMP-9) expression in gastrointestinal malignancy Br. J. Cancer 78 11 1998 1495-1502
30. Pilch H. Schaffer U. Schlenger K. et al. Expression of tenascin in human cervical cancer-association of tenascin expression with clinicopathological parameters Gynecol. Oncol. 73 1999 415-421
31. Riedl S. Kadmon M. Tandara A. et al. Tenascin-C tissue concentration in inflammatory and neoplastic diseases of the colon mucosa Anticancer Res. 17 1997 3165-3166
32. Roeb E. Dietrich C.G. Winograd R. et al. Activity and cellular origin of gelatinases in patients with colon and rectal carcinoma differential activity of matrix metalloproteinase-9 Cancer 92 2001 2680-2691
33. Sarioglu S. Ozer E. Kirimca F. et al. MMP-2 expression in laryngeal preneoplastic and neoplastic lesions Pathol. Res. Pract. 197 2001 483-486
34. Scorilas A. Trangas T. Yotis J. Pateras C. Talieri M. Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin D and clinicopathological characteristics using univariate and multivariate analysis Br. J. Cancer 81 8 1999 1385-1391
35. Shima I. Sasaguri Y. Kusukawa J. et al. Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma Cancer 70 1992 2747-2753
36. Talvensaari-Mattila A. Apaja-Sarkkinen M. Höyhtya M. et al. Matrix metalloproteinase 2 immunoreactive protein appears early in cervical epithelial dedifferentiation Gynecol. Oncol. 72 1999 306-311
37. Tetu B. Brisson J. Lapointe H. Bernard Prognostic significance of stromelysin 3, gelatinase A, and urokinase expression in breast cancer Hum. Pathol. 29 9 1998 979-985
38. Theodoropoulos G.E. Panoussopoulos D. Lazaris A.C. Golematis B.C. Evaluation of cathepsin D immunostaining in colorectal adenocarcinoma J. Surg. Oncol. 65 1997 242-248
39. Upadhyay J. Shekarriz B. Nemeth J.A. et al. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high- grade prostatic intraepithelial neoplasia Clin. Cancer Res. 5 1999 4105-4110
40. Valentini A.M. Pirrelli M. Armentano R. Caruso M.L. The immunohistochemical expression of cathepsin D in colorectal cancer Anticancer Res. 16 1996 77-80
41. Westley B.R. May F.E.B. Prognostic value of cathepsin D in breast cancer Br. J. Cancer 79 2 1999 189-190
42. Yoshida T. Yoshimura E. Numata H. et al. Involvement of tenascin-C in proliferation and migration of laryngeal carcinoma cells Virchows Arch. 435 1999 496-500